Holscher C - Search Results

1

Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia.

Li L, Li YW, Zhao JY, Liu YZ, Holscher C. Li L, et al. Among authors: holscher c. J Clin Neurosci. 2009 Nov;16(11):1466-72. doi: 10.1016/j.jocn.2009.01.020. Epub 2009 Sep 18. J Clin Neurosci. 2009. PMID: 19766498

2

Common pathological processes in Alzheimer disease and type 2 diabetes: a review.

Li L, Hölscher C. Li L, et al. Among authors: holscher c. Brain Res Rev. 2007 Dec;56(2):384-402. doi: 10.1016/j.brainresrev.2007.09.001. Epub 2007 Sep 11. Brain Res Rev. 2007. PMID: 17920690 Review.

3

New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease?

Hölscher C, Li L. Hölscher C, et al. Neurobiol Aging. 2010 Sep;31(9):1495-502. doi: 10.1016/j.neurobiolaging.2008.08.023. Epub 2008 Oct 18. Neurobiol Aging. 2010. PMID: 18930564 Review.

4

Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.

Wang XH, Li L, Hölscher C, Pan YF, Chen XR, Qi JS. Wang XH, et al. Among authors: holscher c. Neuroscience. 2010 Nov 10;170(4):1239-48. doi: 10.1016/j.neuroscience.2010.08.028. Epub 2010 Aug 19. Neuroscience. 2010. PMID: 20727946

5

Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus.

Li L, Holscher C, Chen BB, Zhang ZF, Liu YZ. Li L, et al. Among authors: holscher c. Biol Trace Elem Res. 2011 Dec;143(3):1581-93. doi: 10.1007/s12011-011-8967-3. Epub 2011 Jan 28. Biol Trace Elem Res. 2011. PMID: 21274654

6

(Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.

Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ. Li L, et al. Among authors: holscher c. Eur J Pharmacol. 2012 Jan 15;674(2-3):280-6. doi: 10.1016/j.ejphar.2011.11.005. Epub 2011 Nov 12. Eur J Pharmacol. 2012. PMID: 22115895

7

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease.

Gao C, Hölscher C, Liu Y, Li L. Gao C, et al. Among authors: holscher c. Rev Neurosci. 2011 Dec 21;23(1):1-11. doi: 10.1515/rns.2011.061. Rev Neurosci. 2011. PMID: 22718609 Review.

8

New animal models of Alzheimer's disease that display insulin desensitization in the brain.

Gao C, Liu Y, Li L, Hölscher C. Gao C, et al. Among authors: holscher c. Rev Neurosci. 2013;24(6):607-15. doi: 10.1515/revneuro-2013-0034. Rev Neurosci. 2013. PMID: 24259244 Review.

9

Neuroprotective effects of geniposide on Alzheimer's disease pathology.

Liu W, Li G, Hölscher C, Li L. Liu W, et al. Among authors: holscher c. Rev Neurosci. 2015;26(4):371-83. doi: 10.1515/revneuro-2015-0005. Rev Neurosci. 2015. PMID: 25879319 Free article. Review.

10

Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Liu W, Jalewa J, Sharma M, Li G, Li L, Hölscher C. Liu W, et al. Among authors: holscher c. Neuroscience. 2015 Sep 10;303:42-50. doi: 10.1016/j.neuroscience.2015.06.054. Epub 2015 Jul 2. Neuroscience. 2015. PMID: 26141845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters